Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. [electronic resource]
Producer: 20100503Description: 23-9 p. digitalISSN:- 1879-0720
- Aminoquinolines -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacokinetics
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Humans
- Imidazoles -- pharmacokinetics
- Imiquimod
- Injections, Intraperitoneal
- Injections, Intravenous
- Male
- Melanoma -- drug therapy
- Mice
- Mice, Nude
- Nitrosourea Compounds -- pharmacology
- Organophosphorus Compounds -- pharmacology
- Quinoxalines -- administration & dosage
- Rats
- Skin Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.